2016
DOI: 10.1016/j.orcp.2015.08.004
|View full text |Cite
|
Sign up to set email alerts
|

Synergistic interactions of apigenin, naringin, quercetin and emodin on inhibition of 3T3-L1 preadipocyte differentiation and pancreas lipase activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
32
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 48 publications
(38 citation statements)
references
References 38 publications
2
32
0
Order By: Relevance
“…Guo et al . () similarly found that naringin and emodin synergistically interact to inhibit lipase activities at 0.6 m m . They also observed that apigenin and emodin show synergistic interactions at 0.6 m m .…”
Section: Resultsmentioning
confidence: 82%
See 1 more Smart Citation
“…Guo et al . () similarly found that naringin and emodin synergistically interact to inhibit lipase activities at 0.6 m m . They also observed that apigenin and emodin show synergistic interactions at 0.6 m m .…”
Section: Resultsmentioning
confidence: 82%
“…CI was used to determine the type of interaction, and our results showed that CIs gradually decreased as concentrations increased and reached <0.90 at 50.0 μg mL −1 , suggesting that a synergistic interaction on inhibiting lipase activity only occurred at relative high concentrations of the two compounds. This result was consistent with previous findings (Cai et al ., ; Guo et al ., ). Cai et al .…”
Section: Resultsmentioning
confidence: 97%
“…This indicates that CF partially prevented body weight loss as a result of its hypolipidemic and hypoglycemic effect. Apigenin 7-methyl ether 5-glucoside, a derivative of apigenin, known for its antiobesity properties (Ono and Fujimori, 2011;Guo et al, 2015), was found in CF and may have contributed to reduced visceral fat content and body weight observed in this study. Reports of anti-diabetic effects of other phytochemical constituents of CF are lacking in literature.…”
Section: Discussionmentioning
confidence: 56%
“…Increased activity of these enzymes impairs glycemic control and promotes the development of diabetes (Tundis, Loizzo, & Menichini, 2010). The inhibition upon pancreatic lipase is a target for developing agent(s) to prevent or ameliorate obesity (Guo, Liu, Cai, Wang, & Ji, 2016) because this enzyme analyzes triglycerides into fatty acids and glycerol in the gastrointestinal tract. When the activity of this lipase is limited, triacylglycerol fails to pass cross the intestinal brush border membrane, and subsequently, the uptake of triacylglycerol into the human body is lowered.…”
Section: Introductionmentioning
confidence: 99%